Finch Therapeutics Group, Inc. (FNCHQ) vs Iterum Therapeutics PLC (ITRMF)

Finch Therapeutics Group, Inc. and Iterum Therapeutics PLC are both Biotechnology companies. Finch Therapeutics Group, Inc. and Iterum Therapeutics PLC are of similar size ($1.6M and $1.6M). Finch Therapeutics Group, Inc. has the higher net margin (0.00% vs −2,930.5%) and the higher return on invested capital (0.00% vs −455.5%). Across the 14 metrics below, Finch Therapeutics Group, Inc. leads on 7 and Iterum Therapeutics PLC on 7.

Valuation

Metric FNCHQ ITRMF Biotechnology median
P/E n/m n/m 7.88
P/S 27.07 n/m 11.47
P/B 1.17 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 47.86 24.37 10.73
Earnings yield (85.22%) 0.00% (28.84%)
Free cash flow yield (100.64%) 0.00% (23.03%)

Profitability

Metric FNCHQ ITRMF Biotechnology median
Gross margin 0.00% (81.85%) 65.16%
Operating margin 0.00% (2,243.48%) 0.00%
Net margin 0.00% (2,930.54%) 0.00%
Free cash flow margin 0.00% (2,122.61%) 0.00%
Return on equity (67.28%) 285.48% (57.72%)
Return on assets (25.20%) (111.35%) (49.22%)
Return on invested capital 0.00% (455.51%) 0.00%

Growth

Metric FNCHQ ITRMF Biotechnology median
Revenue growth (TTM) (96.00%) — 5.64%
EPS growth (last fiscal year) 35.36% 57.43% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric FNCHQ ITRMF Biotechnology median
Debt to equity 0.00 (2.87) 0.00
Current ratio 3.87 2.13 4.73
Net debt to EBITDA 0.31 0.24 0.96

Dividend

Metric FNCHQ ITRMF Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric FNCHQ ITRMF Biotechnology median
Market cap 1.57m 1.59m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack